Premium
Super Religare Laboratories Ltd (SRL), a subsidiary of Fortis Healthcare Ltd, is looking to file its draft red herring prospectus (DRHP) with the securities market regulator SEBI to float a public issue in the next six months, a top company executive said.The firm, which is backed by PE firms Avigo ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.